Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibition reduces cardiovascular events in type 2 diabetes (T2DM) and is associated with a reduction in left ventricular (LV) mass index. However, the impact on right ventricular (RV) remodeling is unknown. Accordingly, the objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarak, Bradley, Verma, Subodh, David Mazer, C., Teoh, Hwee, Quan, Adrian, Gilbert, Richard E., Goodman, Shaun G., Bami, Karan, Coelho-Filho, Otávio R., Ahooja, Vineeta, Deva, Djeven P., Garg, Vinay, Gandhi, Sumeet, Connelly, Kim A., Yan, Andrew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491405/
https://www.ncbi.nlm.nih.gov/pubmed/34607574
http://dx.doi.org/10.1186/s12933-021-01390-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491405/
https://www.ncbi.nlm.nih.gov/pubmed/34607574
http://dx.doi.org/10.1186/s12933-021-01390-8

Ejemplares similares